Principal Securities’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,860
Closed -$33.9K 2424
2025
Q3
$33.9K Buy
1,860
+5
+0.3% +$97 ﹤0.01% 2148
2025
Q2
$37.3K Buy
1,855
+761
+70% +$14.6K ﹤0.01% 2020
2025
Q1
$19K Hold
1,094
﹤0.01% 2223
2024
Q4
$19K Buy
1,094
+84
+8% +$1.61K ﹤0.01% 2221
2024
Q3
$19.5K Buy
1,010
+32
+3% +$590 ﹤0.01% 2136
2024
Q2
$16K Buy
978
+402
+70% +$6.24K ﹤0.01% 2181
2024
Q1
$8.78K Buy
576
+105
+22% +$1.65K ﹤0.01% 2392
2023
Q4
$7.55K Buy
+471
New +$6.59K ﹤0.01% 2377

Other funds holding INVA

Principal Securities's INVA Position: Q4 2025 in Review

Principal Securities sold out of Innoviva (INVA) in Q4 2025, closing a stake of 1,860 shares — an estimated $33.9K sold.

Principal Securities first reported a position in INVA in Q4 2023 and held it in 8 quarters. The position peaked at $37.3K in Q2 2025. 280 funds tracked by Wall St. Rank hold INVA as of Q4 2025.

  • Principal Securities reported no remaining Innoviva position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 1,860 Innoviva shares in Q4 2025, an estimated $33.9K.
  • Principal Securities first reported a position in Innoviva in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Innoviva position peaked at $37.3K in Q2 2025.
  • 280 funds tracked by Wall St. Rank held Innoviva as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.